Orbimed Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$64,149,624
-14.3%
529,200
-19.1%
1.36%
+0.4%
Q2 2023$74,896,080
-42.2%
654,000
-30.4%
1.36%
-46.7%
Q1 2023$129,573,983
+2.8%
940,100
-3.3%
2.54%
+5.6%
Q4 2022$125,990,634
+24.1%
972,300
+5.9%
2.41%
+27.9%
Q3 2022$101,531,000
+6673.2%
918,500
+4492.5%
1.88%
+6881.5%
Q2 2022$1,499,000
-50.9%
20,000
-48.8%
0.03%
-46.0%
Q1 2022$3,054,000
-42.2%
39,100
-33.4%
0.05%
-26.5%
Q4 2021$5,286,000
-11.6%
58,700
-9.3%
0.07%
+3.0%
Q3 2021$5,983,000
+18.9%
64,7000.0%0.07%
+29.4%
Q2 2021$5,030,000
-66.3%
64,700
-67.7%
0.05%
-63.6%
Q1 2021$14,927,000
-85.1%
200,278
-66.0%
0.14%
-84.1%
Q4 2020$100,427,000
+32.7%
589,049
+9.3%
0.88%
-7.6%
Q3 2020$75,699,000
-15.6%
539,049
-3.7%
0.95%
-24.7%
Q2 2020$89,734,000
+1.6%
559,649
-38.0%
1.26%
-14.9%
Q1 2020$88,278,000
-10.7%
902,449
+17.8%
1.48%
+5.2%
Q4 2019$98,851,000
+47.9%
766,049
-13.7%
1.41%
+11.3%
Q3 2019$66,835,000
-46.9%
887,349
+7.1%
1.27%
-34.9%
Q2 2019$125,875,000
+27.5%
828,4000.0%1.95%
+27.5%
Q1 2019$98,737,000
+15.8%
828,400
+6.1%
1.53%
-3.0%
Q4 2018$85,231,000
-38.2%
781,000
-8.6%
1.58%
-5.2%
Q3 2018$137,994,000
+130.7%
854,400
+88.8%
1.66%
+132.8%
Q2 2018$59,825,000
+117.3%
452,600
+21.8%
0.71%
+109.4%
Q1 2018$27,532,000
+231.2%
371,600
+148.7%
0.34%
+224.8%
Q4 2017$8,313,000
+22.2%
149,400
-0.4%
0.10%
+61.5%
Q3 2017$6,804,000
-78.2%
150,000
-85.8%
0.06%
-81.6%
Q1 2017$31,207,000
+94.1%
1,054,300
+302.7%
0.35%
+93.4%
Q3 2016$16,077,000261,8000.18%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders